Competitive advantage
Combining merits and avoiding drawbacks of alternatives
The competition of the IntraCross Catheter™ consists of both standard support catheters and crossing devices with their known limitations. Furthermore, there are several startups at a similar stage to ours pushing the limits of the state of the art, albeit with unknown efficacy.
The IntraCross Catheter offers several competitive advantages, making it a game-changer in the treatment of PAD and CTOs.
Safer to cross
The catheter’s centerline crossing mechanism helps minimize the risk of vessel damage, avoiding complex subintimal or re-entry procedures, often seen with traditional methods.
Faster to finish
IntraCross enables physicians to complete procedures in significally less time, offering greater confidence and reducing overall treatment procedure, while also lowering radiation exposure.
Easier to use
IntraCross bridges the gap between highly skilled and less experienced practitioners. This makes it easier for a wider range of physicians to achieve successful outcomes with a similar level of precision.
More cost-effective
IntraCross Catheters are a low-cost solution and not complex crossing devices, making them accessible to clinics worldwide and improving the overall supply chain profitability.
Global Impact
Preventing Amputations
The catheter will help save patients from unnecessary amputations and costly bypass surgeries by providing an alternative, non-invasive solution.
A New Standard in Vascular Care
IntraCross Catheter is positioned to be the treatment of choice for physicians worldwide, revolutionizing how CTOs and PAD are managed.
